ARHGAP5 and neoplasm: The frequency of subcutaneous tumor development in NSG mice was significantly increased in organoids carrying gRNAs targeting Arhgap5 or Mecom compared with that in the non-target gRNA control (Fig. 6e), showing that the two genes are tumor suppressors.